“…Nonetheless, 11 carboxamides were active at concentrations between 31.25 and 62.5μg/mL, an important outcome, as earlier findings had demonstrated that C3/C7-acyl/carboxamidotetramates in most cases suffered from either partial or complete loss of efficacy under similar conditions . As tetramic acids are well-known metal chelators, , of interest was to investigate whether this loss of activity was due to metal chelation or plasma protein binding (PPB), specifically with human serum albumin (HSA). , To answer this question, bicyclic tetramate 12a was tested against MRSA using a broth dilution assay, under standard conditions and with the addition of similar metal cations (Fe, Ca, Mg, and Zn) with concentration as that found in blood, respectively. The activity was found to be slightly improved for the latter {0.49 vs 0.24 [MIC (μg/mL) against MRSA]}, suggesting that the weaker metal chelating properties of these aryl-substituted tetramates discussed above may be important for in vivo activity in therapeutic application.…”